INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2024

Gestational diabetes affects about 14% of global pregnancies, with trials showing benefits of treating early and late gestational diabetes.

This review examines the epidemiology and management of gestational diabetes, which affects around 14% of pregnancies globally and incurs US$1.6 billion in direct costs in the USA. Between 30% and 70% of cases are diagnosed before 20 weeks of gestation, with early gestational diabetes associated with worse outcomes than diagnosis at 24 to 28 weeks. Randomized controlled trials demonstrate the benefits of treating gestational diabetes at 24 to 28 weeks, and the TOBOGM trial showed benefits from diagnosing and treating early gestational diabetes in women with risk factors.

Study type
Narrative review
Who was studied
Pregnant women globally affected by gestational diabetes
What was measured
Gestational diabetes epidemiology, diagnosis, and treatment outcomes

THE PAPER

Epidemiology and management of gestational diabetes.

Sweeting A, Hannah W, Backman H, Catalano P, Feghali M, Herman WH, Hivert MF, Immanuel J, Meek C, Oppermann ML, Nolan CJ, Ram U, Schmidt MI, Simmons D, Chivese T, Benhalima K. Lancet, 2024.

PubMed 38909620 ↗DOI 10.1016/s0140-6736(24)00825-0 ↗

Diabetes & blood sugarBlood pressureWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.